UNSPSC 41141926: Biotinidase test system

In this classification, Biotinidase test system connotes a device used to measure Biotinidase levels. US FDA regulates Biotinidase test system under 21 CFR 862.1118 and under FDA product code NAK.

UNSPSC 41141926 Biotinidase test system is a Commodity code under which state and local governments procure laboratory diagnostic reagent kits and certified reference materials for forensic, public health, and clinical laboratory operations. Recent solicitations show that the code captures immunoassay testing kits for substance screening, DNA analysis kits, certified drug reference standards for method validation, and specialized test equipment used in forensic toxicology and state health agency laboratories. Issuing bodies include state law enforcement and public safety departments, state health and human services agencies, county forensic laboratories, and state departments of financial and professional regulation. The work spans both consumable reagents and reference standards with specific chemical and analytical specifications, as well as associated laboratory equipment and test readers required for analytical operations.

State and local activity under this code concentrates in Texas and Florida, with additional activity in Illinois. Recent opportunities include the Texas Department of Public Safety's IFB 405-26R0008445A (posted July 9, 2026, due July 23, 2026) soliciting immunoalysis reagent kits for direct ELISA testing across multiple drug classes with quantities ranging from 3 to 30 units per line item; Pinellas County, Florida's ITQ 26-0305-ITQ (posted and due April 23, 2026) procuring 131 line items of certified drug reference standards exceeding 97% purity for forensic laboratory validation and evidentiary analysis, funded at $49,034.00 through the Paul Coverdell Forensic Sciences Improvement Act; the Texas Health and Human Services Commission's IFB HHS0016902v2 (due January 29, 2026) for QIAxcel and QIAamp DNA screening kits with historical spend guidance of $25,050.00 to $30,000.00 for fiscal 2025; and Illinois Department of Financial and Professional Regulation's joint purchase master contract (posted May 4, 2026, notice of intent to award) for RAMP West Nile Virus and Dengue test kits through sole source procurement.